Modular Product Pipeline & Potential Applications

The Bottleneck

Raw milk matrices (fats and proteins) typically inhibit molecular reactions, frequently causing long delays for off-site lab results while subclinical infections spread.

Our Next Steps

Over the next 6 months, we are launching targeted research initiatives focused on validating and optimizing our core technology specifically for the raw milk matrix.

The Proposed Mechanism

This phase aims to adapt our modular architecture to seamlessly isolate background caseins and fats, concentrating target bacterial DNA directly from the sample.

Market Landscape

While the immediate global commercial product market for mastitis management is $2.3 Billion (projected to reach $4.0 Billion by 2035), our automated, on-farm approach directly targets the broader $32 Billion in annual economic losses currently absorbed by the international dairy industry.

The Bottleneck

Traditional sputum collection is invasive and highly viscous, whereas more accessible oral gargles are often too dilute for standard diagnostic kits.

The Proclaimed Need

Global bodies like the WHO and the Stop TB Partnership have explicitly called for an urgent shift toward non-sputum, near point-of-care testing to eliminate laboratory infrastructure barriers.

The Proposed Mechanism

We hypothesize that our high-pressure microfiltration can safely isolate and concentrate low-abundance TB pathogens from a simple, non-invasive oral rinse solution.

Target Market Size

$2.70 Billion globally in 2026 (projected to reach $4.08 Billion by 2034), accelerated by active international procurement initiatives.

The Bottleneck

Capturing trace pathogens in large liquid volumes currently forces facilities to endure a standard 24-hour incubation phase to grow bacteria to detectable levels.

The Proposed Mechanism

The platform is designed to physically condense target pathogens from large-volume (10mL–30mL) rinses instantly onto our collection membrane.

Potential Value

Our goal is to significantly shorten the required enrichment phase, drastically cutting down overall processing time to get products cleared faster.

Target Market Size

$16.49 Billion globally in 2026 (with the rapid molecular segment accelerating at a 9.2% CAGR).